Olusanya A. Rufai, MD
Legal Medicine · Brooklyn, NY
Olusanya A. Rufai, MD is a legal medicine with a practice address in Brooklyn, New York, and NPI 1316964943, issued on Jul 17, 2006. Check the license (New York 237644, as entered in NPPES) with the New York board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Olusanya A. Rufai
- Credential
- MD
- Primary taxonomy
- Legal Medicine 173000000X
- License number
- 237644 NY
Self-reported in NPPES; status is on the state search - Practice location
- 598 New York Avenue, Brooklyn, NY 11203
- Phone
- (718) 693-4121
- Enumerated
- Jul 17, 2006
- Record last updated
- Feb 16, 2010 (not updated in 16 years: call before relying on the address or phone)
- Medicaid ID
- 02080211 NY
- Medicare enrollment
- Enrolled (PECOS I20040525000493); may accept Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest legal medicine records → All 112 in New York → Look up another NPI →
Verify Olusanya A. Rufai in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich New York board licenses this profession
Search for license 237644Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
3.9 times the Medicare Part D claims of the average legal medicine in 2024
9,989 Medicare Part D claims for 690 beneficiaries, against an average of 2,531 among the 246 providers of this specialty who prescribed in Part D. Brand-name drugs were 11% of claims. 13 claims were for opioids.
Most prescribed
- Amlodipine Besylate618 claims
- Atorvastatin Calcium439 claims
- Omeprazole403 claims
- Losartan Potassium377 claims
- Losartan-Hydrochlorothiazide323 claims
- Nifedipine Er316 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 98.8 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $51.56
2 payments; by number, the most common kind was food and beverage; the largest payer was Theratechnologies Inc. The 144 providers of this specialty with any payment received $4,618.84 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Olusanya A. Rufai among 112 legal medicine records in New York
Olusanya A. Rufai, MD is one of 112 legal medicine records with a practice address in New York. 46% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 8% of them.
- NPI issued2006 · 8% of these records are older, 30% newer
- In a Medicare fileYes · 46% of these records are
- In the CMS Doctors and Clinicians fileYes · 27% of these records are
- Graduated1987 · median 1987 among the 30 with a school on file
- Record last updated2010 · 81% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 173000000X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Legal Medicine providers in New York
There are 112 legal medicine records in New York.
All 112 in New York → Every provider in Brooklyn → Legal Medicine nationwide →
The 8 legal medicine records with the nearest ZIP codes
- Asha Pandey, MDBrooklyn, NY 112031841279031
- Lyudmila Poretskaya, M.D.Brooklyn, NY 112041558386409
- Karl LatortueBrooklyn, NY 112011104861558
- Dale Alexander, MDBrooklyn, NY 112061023185659
- Florecita DonaireBrooklyn, NY 112061982776688
- Camille CampbellBrooklyn, NY 112101366282618
- Paul Cohen, MDBrooklyn, NY 112131760462436
- Guy Regev, MDBrooklyn, NY 112181215566674
Common questions
What is Olusanya A. Rufai, MD's NPI number?
Olusanya A. Rufai, MD's National Provider Identifier (NPI) is 1316964943, issued on Jul 17, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Olusanya A. Rufai, MD located?
The NPPES record lists a practice address at 598 New York Avenue, Brooklyn, NY, 11203. Phone: (718) 693-4121. Providers update this record themselves, so call before visiting.
How can I verify Olusanya A. Rufai, MD's license?
NPPES lists New York license number 237644, as entered by the provider. Search the New York board that licenses this profession; the NPPES record confirms identity only.
How much does Olusanya A. Rufai, MD prescribe under Medicare Part D?
In 2024, Olusanya A. Rufai, MD had 9,989 Medicare Part D claims for 690 beneficiaries; the average among legal medicine prescribers was 2,531. Part D covers Medicare prescriptions only.
What is Olusanya A. Rufai, MD's MIPS final score?
The 2023 MIPS final score is 98.8 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.